arrow
M

Mohamed K. Elgohary

Egyptian Russian University
H指数:10
被引数:248

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Unlocking the antidiabetic potential of novel pyrazole-triazole hybrids through synthesis; dual α-amylase/α-glucosidase inhibition; multiscale biological evaluation; and molecular dynamics studies

通过合成解锁新型吡唑-三唑杂合体的降糖潜力;双重α-淀粉酶/α-葡萄糖苷酶抑制;多尺度生物评价;以及分子动力学研究

2026-06-030
OA
Harnessing benzofuran scaffolds: A journey through design, synthesis, and biological discovery toward safer anti-diabetic and anti-oxidant candidates

利用苯并呋喃骨架:从设计、合成到生物发现的旅程,旨在获得更安全的抗糖尿病和抗氧化候选物

2025-10-090
PRE
Design and evaluation of 2-(4-((2-(2-((2,6-dichloro-3-methylphenyl)amino)benzoyl)hydrazineylidene)methyl)phenoxy)acetic acid as a dual anti-inflammatory and anti-diabetic agent

2-(4-((2-(2-((2,6-二氯-3-甲基苯基)氨基)苯甲酰)肼叉基)甲基)苯氧基)乙酸作为双重抗炎和抗糖尿病药物的设计与评价

2025-09-010
PRE
Design, synthesis and biological evaluation of pyrazolo[3,4-b]pyridine derivatives as dual CDK2/PIM1 inhibitors with potent anti-cancer activity and selectivity

吡唑并[3,4-b]吡啶衍生物的设计、合成及其作为具有强效抗肿瘤活性和选择性的CDK2/PIM1双靶点抑制剂的生物活性评价

2025-03-130
PRE
Exploring antitumor activity of novel imidazo[2,1-b]thiazole and imidazo [1,2-a]pyridine derivatives on MDA-MB-231 cell line: Targeting VEGFR-2 enzyme with computational insight

探索新型咪唑并 [2,1-b] 噻唑和咪唑并 [1,2-a] 吡啶衍生物对MDA-MB-231细胞系的抗肿瘤活性: 具有计算洞察力的靶向VEGFR-2酶

2025-02-013
PRE
Molecular docking, DFT and antiproliferative properties of 4-(3,4-dimethoxyphenyl)-3-(4-methoxyphenyl)-1-phenyl-1H-pyrazolo[3,4-b]pyridine as potent anticancer agent with CDK2 and PIM1 inhibition potency

4-(3,4-二甲氧基苯基)-3-(4-甲氧基苯基)-1-苯基-1h-吡唑并 [3,4-b] 吡啶作为具有CDK2和PIM1抑制效力的有效抗癌剂的分子对接,DFT和抗增殖特性

2024-10-283
PRE
Design, Synthesis, and Biological Evaluation of Novel Phenoxy Acetic Acid Derivatives as Selective COX-2 Inhibitors Coupled with Comprehensive Bio-Pharmacological Inquiry, Histopathological Profiling, and Toxicological Scrutiny

作为选择性COX-2抑制剂的新型苯氧基乙酸衍生物的设计,合成和生物学评估,以及全面的生物药理学研究,组织病理学分析和毒理学审查

2024-03-156
OAAI